[Federal Register Volume 82, Number 82 (Monday, May 1, 2017)]
[Notices]
[Pages 20341-20343]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-08705]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-17-17AW]
Agency Forms Undergoing Paperwork Reduction Act Review
The Centers for Disease Control and Prevention (CDC) has submitted
the following information collection request to the Office of
Management and Budget (OMB) for review and approval in accordance with
the Paperwork Reduction Act of 1995. The notice for the proposed
information collection is published to obtain comments from the public
and affected agencies.
Written comments and suggestions from the public and affected
agencies concerning the proposed collection of information are
encouraged. Your comments should address any of the following: (a)
Evaluate whether the proposed collection of information is necessary
for the proper performance of the functions of the agency, including
whether the information will have practical utility; (b) Evaluate the
accuracy of the agencies estimate of the burden of the proposed
collection of information, including the validity of the methodology
and assumptions used; (c) Enhance the quality, utility, and clarity of
the information to be collected; (d) Minimize the burden of the
collection of information on those who are to respond, including
through the use of appropriate automated, electronic, mechanical, or
other technological collection techniques or other forms of information
technology, e.g., permitting electronic submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570 or send an email to [email protected]. Written
[[Page 20342]]
comments and/or suggestions regarding the items contained in this
notice should be directed to the Attention: CDC Desk Officer, Office of
Management and Budget, Washington, DC 20503 or by fax to (202) 395-
5806. Written comments should be received within 30 days of this
notice.
Proposed Project
Assessment of Targeted Training and Technical Assistance (TTA)
Efforts on the Implementation of Comprehensive Cancer Control--New--
National Center for Chronic Disease Prevention and Health Promotion
(NCCDPHP), Centers for Disease Control and Prevention (CDC).
Background and Brief Description
The Centers for Disease Control and Prevention's (CDC) National
Comprehensive Cancer Control Program (NCCCP) has been a primary funder
for state and community-based cancer control interventions since its
inception in the late 1990s. In addition, CDC's Office on Smoking and
Health (OSH) also has worked to build state health department
infrastructure and capacity to conduct coordinated comprehensive
tobacco prevention and control activities which contribute to cancer
health outcomes through the provision of funding to state health
departments and local partners through the Nation State Based Tobacco
Control Program (NSTB).
In striving to build capacity and maximize the impact of CDC's
funded programs, CDC has focused on developing and implementing
innovative programs to enhance the training and technical assistance
(TTA) delivered to NCCCP and NSBT grantee programs. CDC funds 10
organizations under two cooperative agreements: The Consortium of
National Networks to Impact Populations Experiencing Tobacco-Related
and Cancer Health Disparities (DP13-1314), and National Support to
Enhance Implementation of Comprehensive Cancer Control Activities
(DP13-1315). Under these cooperative agreements, DP13-1314 and DP13-
1315 awardees provide TTA to state NCCCP and NSBT grantees to support
local implementation of high-impact public health strategies. Using two
different TTA models, DP13-1314 and DP13-1315 aim to impact both short-
and long-term outcomes on the awardee, NCCCP program, and population
levels.
CDC proposes to conduct an assessment of the DP13-1314 and DP13-
1315 cooperative agreements to: (1) Increase CDC's understanding of the
TTA provided to NCCCP and NSTB grantees across both cooperative
agreements, (2) help identify the extent to which core elements of the
TTA were administered, and (3) determine the elements of TTA across
both cooperative agreements that show promise for improving NCCCP and
NSTB capacity. There are no other data collection efforts currently
underway to assess implementation of the two TTA models or their
perceived effectiveness.
This information collection request will involve three
complementary data collection efforts: (1) Case studies of DP13-1314
and DP13-1315 awardees (consisting of interviews with DP13-1314 and
DP13-1315 program managers/directors, evaluators, and partners); (2) a
cross-sectional web-based survey administered to NCCCP and NSBT program
directors, coalition members, and partners; and (3) in-depth interviews
with selected NCCCP and NSBT program directors, staff, coalition
members, and partners who received a high volume of TTA from one or
more of the DP13-1314 and DP13-1315 awardees. The case studies will be
used to explore how DP13-1314 and DP13-1315 awardees are implementing
their respective cooperative agreements and administering TTA to NCCCP
and NSBT grantees; the factors that affect the implementation of
specific TTA components; and the extent to which each cooperative
agreement was able to achieve planned short-term outcomes. The Web-
based survey will inform CDC's understanding of the reach of DP13-1314
and DP13-1315 TTA efforts; elicit information from NCCCP and/or NSBT
programs and coalitions about the TTA received, including type, dosage,
frequency and format; and assess the perceptions of the effectiveness
of the TTA provided in building capacity to achieve intended outcomes.
The in-depth interviews with ``high-volume'' TTA users will facilitate
an in-depth exploration of the type and quality of TTA activities
received; perceived quality of TTA and its contributions to NCCCP and
NSBT grantee program implementation, and achievement of CDC priorities
and goals.
CDC will use findings from the assessment to inform development of
future TTA efforts that utilize the core elements across the two models
to more effectively and efficiently support NCCCP's partner
organizations.
OMB approval is requested for 2 years. Participation is voluntary
and respondents will not receive incentives for participation. There
are no costs to respondents other than their time. The total estimated
annualized burden hours are 231.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondents Form name Number of responses per per response
respondents respondent (in hours)
----------------------------------------------------------------------------------------------------------------
DP13-1314 and DP13-1315 Awardee Worksheet for 5 1 1
Organizations. Identifying Case Study
Interviewees.
DP13-1314 Program Directors/Managers.. Case Study Interview 4 1 1.5
Guide for DP13-1314
Program Directors/
Managers.
Case Study Follow-Up 4 1 1
Interview Guide for
DP13-1314 Program
Directors/Managers.
DP13-1315 Directors/Managers.......... Case Study Interview 1 1 1.5
Guide for DP1-1315
Program Directors/
Managers.
Case Study Follow-Up 1 1 1
Interview Guide for DP1-
1315 Program Directors/
Managers.
DP13-1314 Evaluators.................. Case Study Interview 4 1 1
Guide for DP1-1314
Evaluators.
DP13-1315 Evaluators.................. Case Study Interview 1 1 1
Guide for DP1-1315
Evaluators.
DP13-1314 Partners.................... Case Study Interview 8 1 1
Guide for DP1-1314
Partners.
[[Page 20343]]
DP13-1315 Partners.................... Case Study Interview 2 1 1
Guide for DP1-1315
Partners.
NCCCP and NSBT Program Directors, Web-based survey........ 780 1 15/60
Staff, Coalition Members, and
Partners.
NCCCP and NSBT Program Directors, In-Depth Interview Guide 5 1 0.5
Staff, Coalition Members, and
Partners.
----------------------------------------------------------------------------------------------------------------
Leroy A. Richardson,
Chief, Information Collection Review Office, Office of Scientific
Integrity, Office of the Associate Director for Science, Office of the
Director, Centers for Disease Control and Prevention.
[FR Doc. 2017-08705 Filed 4-28-17; 8:45 am]
BILLING CODE 4163-18-P